The downregulation of the CD40–CD40L-signaling pathway inactivates matrix metalloproteinase 2 (MMP-2) and MMP-9 in human umbilical vein endothelial cells (HUVECs) and reduces inflammatory responses in atherosclerosis [54]. Here, MMP2 is linked to atherosclerosis.